Stockscreener 앱 받기
16.28
0.61%
-0.10
시간 외 거래:
16.50
0.22
+1.35%
전일 마감가:
$16.38
열려 있는:
$16.25
하루 거래량:
1.23M
Relative Volume:
0.64
시가총액:
$2.38B
수익:
$340.81M
순이익/손실:
$-419.65M
주가수익비율:
-5.7123
EPS:
-2.85
순현금흐름:
$-402.10M
1주 성능:
+2.01%
1개월 성능:
+12.12%
6개월 성능:
-2.22%
1년 성능:
-37.29%
1일 변동 폭
$15.90
$16.45
1주일 범위
$15.90
$17.02
52주 변동 폭
$10.57
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
명칭
Denali Therapeutics Inc
전화
(650) 866-8547
주소
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
16.28 | 2.39B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | 재개 | Morgan Stanley | Overweight |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2025-01-07 | 개시 | Robert W. Baird | Outperform |
| 2025-01-03 | 개시 | William Blair | Outperform |
| 2024-12-16 | 업그레이드 | Stifel | Hold → Buy |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-10-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | 개시 | Citigroup | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 개시 | B. Riley Securities | Buy |
| 2023-01-30 | 개시 | SVB Securities | Outperform |
| 2022-12-05 | 개시 | Cowen | Outperform |
| 2022-11-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-02 | 개시 | BofA Securities | Buy |
| 2022-06-23 | 개시 | Berenberg | Buy |
| 2021-12-10 | 재개 | Raymond James | Mkt Perform |
| 2021-09-21 | 개시 | Oppenheimer | Outperform |
| 2021-09-01 | 개시 | SMBC Nikko | Outperform |
| 2021-05-18 | 개시 | UBS | Buy |
| 2021-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-08-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-02-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-02-24 | 개시 | Jefferies | Buy |
| 2020-02-19 | 개시 | Stifel | Hold |
| 2020-01-27 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-09-26 | 개시 | Wedbush | Neutral |
| 2019-09-13 | 개시 | Nomura | Buy |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
| 2018-11-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | Janney | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 개시 | Goldman | Neutral |
| 2018-01-02 | 개시 | JP Morgan | Overweight |
| 2018-01-02 | 개시 | Morgan Stanley | Overweight |
모두보기
Denali Therapeutics Inc 주식(DNLI)의 최신 뉴스
Comparing Denali Therapeutics Inc. in custom built stock radarsWeekly Trade Review & Real-Time Volume Analysis - newser.com
Why analysts remain bullish on Denali Therapeutics Inc. stockPrice Action & Growth Focused Investment Plans - newser.com
Is Denali Therapeutics Inc. stock a top momentum playGlobal Markets & Accurate Trade Setup Notifications - newser.com
Can Denali Therapeutics Inc. (4DN) stock test all time highsJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Is Denali Therapeutics Inc. stock a contrarian buyStop Loss & Growth Focused Investment Plans - newser.com
Pier Capital LLC Sells 20,708 Shares of Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc. $DNLI Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
Published on: 2025-11-02 03:18:16 - newser.com
Will Denali Therapeutics Inc. (4DN) stock enhance shareholder valueStock Surge & Free Safe Entry Trade Signal Reports - newser.com
Detecting price anomalies in Denali Therapeutics Inc. with AIPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com
Is Denali Therapeutics Inc. stock ready for a breakoutGDP Growth & Consistent Profit Trade Alerts - newser.com
Will Denali Therapeutics Inc. (4DN) stock outperform small cap peers2025 Dividend Review & Stepwise Trade Execution Plans - newser.com
Is Denali Therapeutics Inc. stock a dividend growth opportunityQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Savvy Advisors Inc. Invests $1.37 Million in Denali Therapeutics Inc. $DNLI - MarketBeat
Denali Therapeutics Inc expected to post a loss of 75 cents a shareEarnings Preview - TradingView
Applying sector rotation models to Denali Therapeutics Inc.Fed Meeting & Safe Capital Growth Stock Tips - newser.com
Does Denali Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesShort Setup & Verified Swing Trading Watchlists - newser.com
Will Denali Therapeutics Inc. stock rally after Fed decisionsJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
How Denali Therapeutics Inc. (4DN) stock gains from tech spendingEarnings Risk Report & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-10-30 23:48:28 - newser.com
Denali Therapeutics (DNLI) to Release Quarterly Earnings on Wednesday - MarketBeat
Published on: 2025-10-29 04:42:36 - newser.com
Denali Therapeutics Inc (DNLI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):